@berger0413
Research Officer | Communicable Disease Nurse | Certified in Infection Prevention and Control (CIC) | Credentialled Infection Control Professional (CICP-P) πVancouver, British Columbia π¨π¦π¦πΊπ΄σ §σ ’σ ³σ £σ ΄σ Ώπ³οΈβπ
In a recent narrative review, we examined research on mpox-related stigma and prevention, including vaccination, among gay, bisexual, and other men who have sex with men (GBMSM). doi.org/10.3390/heal...
@mdpiopenaccess.bsky.social
Our new research has validated the MAPVac scale, a tool to measure how adults perceive microarray patches (MAPs) for vaccination!
The MAPVac scale showed strong reliability and measures attitudes toward MAP vaccination safety, ease of use, and acceptability.
Read more: doi.org/10.1016/j.va...
Our new study explored how older adults (50+) perceive High-Density Microarray Patches (HD-MAPs), a painless and easy-to-use vaccine patch. Participants appreciated the convenience, potential for self-use, and reduced burden on healthcare systems.
Read more here: doi.org/10.1016/j.hl...
Grateful to be invited to share our findings in Weenipagamiksaguygun (Winnipeg, Canada) on microarray patch (MAP) vaccination at Public Health 2025. Itβs wonderful to see all the amazing work being done across Canada.
We would like to invite you to take part in a research project on vaccine patches, which are a new vaccine delivery method under development.
We are looking for people aged 18 years and older living in Australia, Canada, New Zealand and the UK.
redcap.sydney.edu.au/surveys/?s=J...